Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria

Background The long-acting somatostatin analog lanreotide autogel is effective in the treatment of patients with neuroendocrine tumors. Objective To evaluate the long-term treatment response in patients with neuroendocrine tumors receiving lanreotide autogel in routine clinical practice. Methods Non...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinke, Anja, Maintz, Christoph, Müller, Lothar, Weber, Matthias M., Lahner, Harald, Pavel, Marianne, Saeger, Wolfgang, Houchard, Aude, Ungewiss, Hanna, Petersenn, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298132/
https://www.ncbi.nlm.nih.gov/pubmed/34293802
http://dx.doi.org/10.1055/a-1342-2755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298132/
https://www.ncbi.nlm.nih.gov/pubmed/34293802
http://dx.doi.org/10.1055/a-1342-2755

Ejemplares similares